Universität zu Köln

Cramer, Paula, Langerbeins, Petra, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2016). Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all? Leuk. Lymphoma, 57 (5). S. 987 - 991. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Cramer, Paula UNSPECIFIED UNSPECIFIED UNSPECIFIED Langerbeins, Petra UNSPECIFIED UNSPECIFIED UNSPECIFIED Fischer, Kirsten UNSPECIFIED UNSPECIFIED UNSPECIFIED Eichhorst, Barbara UNSPECIFIED UNSPECIFIED UNSPECIFIED Hallek, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Goede, Valentin UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-290215
DOI:	10.3109/10428194.2016.1164858
Journal or Publication Title:	Leuk. Lymphoma
Volume:	57
Number:	5
Page Range:	S. 987 - 991
Date:	2016
Publisher:	TAYLOR & FRANCIS LTD
Place of Publication:	ABINGDON
ISSN:	1029-2403
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language PREVIOUSLY UNTREATED PATIENTS; ILLNESS RATING-SCALE; PHASE-3 TRIAL; OPEN-LABEL; CLL; CHEMOIMMUNOTHERAPY; THERAPY; CHLORAMBUCIL; OBINUTUZUMAB; OFATUMUMAB Multiple languages Oncology; Hematology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/29021